Pancreatic Cancer Research

ResearcherCasa Sollievo della SofferenzaActive in the last 2 years

Annacandida Villani

Matched on ORCID iD 0000-0001-5840-8306; OpenAlex author ID A5000167030. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. Comparative Analysis of Fecal Microbiota in Healthy Controls and Pancreatic Cancer Patients: A Focus on Tumor Localization Differences in Pancreatic Head and B… Co-author DOI 10.1002/cam4.71450↗
  2. A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic p… Co-author DOI 10.1080/19490976.2024.2375483↗
  3. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS G12D mutated pancreatic cancer in vivo model. Co-author DOI 10.1038/s41420-023-01397-y↗
  4. Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models. First author DOI 10.1016/j.biopha.2022.113163↗
  5. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspe… Co-author DOI 10.1016/j.semcancer.2021.11.007↗
  6. Tuning gut microbiota through a probiotic blend in gemcitabine-treated pancreatic cancer xenografted mice. Co-author DOI 10.1002/ctm2.580↗
  7. Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels. Co-author DOI 10.3390/biom11050639↗
  8. High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreati… Co-author DOI 10.3390/biom11010026↗
  9. High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice. First author DOI 10.3390/nu11040709↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Concetta Panebianco · 9 shared papers, 2019–2025 · strength 1.41
  2. Valerio Pazienza · 9 shared papers, 2019–2025 · strength 1.41
  3. Francesco Perri · 8 shared papers, 2020–2025 · strength 1.25
  4. Tiziana Pia Latiano · 8 shared papers, 2020–2025 · strength 1.25
  5. Evaristo Maiello · 3 shared papers, 2022–2025 · strength 0.58
  6. Nadia Trivieri · 2 shared papers, 2020–2021 · strength 0.25
  7. Andrea Fontana · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.